Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

Date first appeared online	22/06/2016
DOI	10.1016/s2468-1253(16)30003-6
Authors	Alam F., Alrubaiy L., Hutchings H., Watkins A., Williams J.
Journal Name	The Lancet Gastroenterology & Hepatology
Volume	1

Documents

• 1-s2.0-S2468125316300036-mainVOR.pdf , Book, Distributed under the terms of a Creative Commons Attribution CC-BY Licence.